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Background: A new term, dysmobility syndrome, has recently been described as a new 
approach to identify older people at risk of poor health outcomes. The aim was to undertake a 
systematic review of the existing research literature on dysmobility syndrome.
Method: All articles reporting dysmobility syndrome were identified in a systematic review 
of Medline (Proquest), CINAHL, PubMed, PsycInfo, EMBASE, and Scopus databases. Key 
characteristics of identified studies were extracted and summarized.
Results: The systematic review identified five papers (three cross-sectional, one case control, 
and one longitudinal study). No intervention studies were identified. Prevalence of dysmobility 
syndrome varied between studies (22%–34% in three of the studies). Dysmobility syndrome was 
shown to be associated with reduced function, increased falls and fractures, and a longitudinal 
study showed its significant association with mortality.
Conclusion: Early research on dysmobility syndrome indicates that it may be a useful 
classification approach to identify older people at risk of adverse health outcomes and to target 
for early interventions. Future research needs to standardize the optimal mix of measures and cut 
points, and investigate whether balance performance may be a more useful factor than history 
of falls for dysmobility syndrome.
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Introduction
Increasing age is associated with a decline in function of all systems involved in 
physical and cognitive functions. However, it is important to differentiate decline in 
these systems that is purely associated with normal aging, from that caused by health 
conditions (both diagnosed and non-diagnosed or subclinical) or through environmental 
and behavioral constraints (eg, sedentary behavior). While normal aging is associated 
with similar system declines but of a much milder magnitude, these declines do not 
generally impact upon daily activities and independence until advanced age. In contrast, 
health conditions, environmental and behavioral factors can have substantial impact 
on independence, function, and quality of life, even at relatively young stages of older 
age (eg, in the 60s).
For many years, geriatricians and gerontologists have been exploring a number of 
classifications in an attempt to accurately identify older people most at risk of serious 
declines in health, independence, and function. Accurate identification provides the 
potential to target appropriate and effective interventions to this cohort, aiming to slow 
down or reverse this decline. In particular, early recognition of decline or risk of decline 
provides the greatest opportunity for prevention or reversal through intervention. Over 
25 years ago, the term sarcopenia was introduced following a meeting of researchers 
and clinicians in the USA seeking to identify and group key components of functional 
decline.1 There are a number of consensus definitions of sarcopenia, and although there 
is variability in the criteria used to define sarcopenia, each includes measures of muscle 
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mass and muscle function.2–6 The focus on sarcopenia over 
recent years has resulted in substantial growth in descriptive, 
predictive, and interventional studies.
A limitation of the sarcopenia focus is that irrespective 
of the criteria and cut points used, an essential component of 
the diagnosis is the presence of low muscle mass. However, 
some older people with normal range muscle mass are still at 
high risk or do develop the adverse health outcomes discussed 
above, and it has been recognized that muscle mass needs 
to be considered among a broader range of equally relevant 
areas of assessment.7,8 A similar case has been put forward 
regarding the diagnosis of osteoporosis in isolation.9,10 
Definitions of sarcopenia continue to be modified over time 
with additional domains of assessment.8 Several researchers 
have identified that although there has been substantial 
research published in the sarcopenia area, clinical uptake 
of the application of the definitions and utilization to drive 
clinical interventions has been relatively poor.4,9
During the same time period, to address the concern that 
the focus on only muscle strength and muscle mass was too 
narrow in both identifying people at risk of decline and to 
inform intervention development and implementation, other 
researchers developed the term “frailty”.11,12 A number of 
definitions and criteria for frailty have been published.11–15 
These have generally included a measure of muscle strength, 
but also additional factors such as loss of weight, fatigue, 
and low levels of physical activity.
More recently, these terms have come under criticism 
as they do not consider the potential interaction between 
conditions and may be a limiting factor in recognizing 
and implementing comprehensive interventions that may 
be effective across these disorders.9 Hence, a new term – 
dysmobility syndrome – has been developed by Binkley et al9 
to incorporate a more diverse range of factors that may be a 
better predictor of adverse health outcomes for older people. 
The six factors recommended were as follow: osteoporosis, 
falls in the preceding year, obesity/high fat mass, low lean 
mass, slow gait speed, and low grip strength. The classifica-
tion of dysmobility syndrome was proposed if three or more 
of these factors were present. The Binkley classification did 
not require any essential or pre-requisite elements, so any 
combination of three or more of these factors is consid-
ered indicative of the presence of dysmobility syndrome. 
Binkley et al9 have proposed draft cut point criteria for each 
of these factors (Table 1).
Although Binkley et al’s study9 provides a recom-
mended framework for the factors to include in the clas-
sification of dysmobility syndrome and cut points for each 
of the six factors, the authors also conclude that “the factors 
chosen and cut points applied here are almost certainly 
not ideal”.
The purpose of this review is to conduct a systematic 
review of the current published research on dysmobility 
syndrome.
Method
A systematic review of the Medline (Proquest), CINAHL, 
PubMed, PsycInfo, EMBASE, and Scopus databases was 
conducted, for papers published from January 1975 to 
August 2016. Criteria for papers to be included in the review 
were as follow: 1) target population was community-dwelling 
older people and 2) research investigating prevalence of 
dysmobility syndrome, factors associated with dysmobility 
syndrome, adverse outcomes associated with dysmobility 
syndrome, or evaluating an intervention for people with 
dysmobility syndrome. Given that this is a relatively newly 
described syndrome, all paper types except descriptive and 
review papers were included, (eg, case study, cross-sectional, 
longitudinal, and intervention papers were included). Only 
papers published in peer reviewed journals and written in 
English were included. Reference lists of identified papers 
were also searched for additional papers. The search terms 
used for this systematic review were dysmobility or dysmob*, 
and the relevant year range was also entered. The search, 
screen, and data extraction were undertaken by KF and 
replicated by EB. Any disagreement regarding inclusion 
or exclusion of papers was resolved by review by a third 
author (KH).
Identified papers were grouped according to their type into 
1) case control, cross-sectional, or longitudinal studies and 
2) interventions to address dysmobility syndrome. Key charac-
teristics of papers were extracted and summarized in tables.
Table 1 Proposed factors and cut point scores for classification 
of dysmobility syndrome (requires three or more of the factors 
to be present)
Factor Recommended cut point for impairment
Osteoporosis T-score of #-2.5 at lumbar spine, femoral 
neck, or total proximal femur
Falls in the preceding year Self-report of one or more falls
Low lean mass Appendicular lean mass #5.45 kg/m2 
(females) or #7.26 kg/m2 (males)
Slow gait speed ,1.0 m/s (comfortable speed)
Low grip strength Hand-held dynamometer: ,30 kg (male); 
,20 kg (female)
Obesity/high fat mass Total body % fat: .30 for males: .40 for 
females
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Figure 1 reports the results of the systematic review search. 
Following the exclusion of duplicates and papers not meet-
ing the other inclusion criteria, five papers were retained for 
full review. These included three cross-sectional studies,9,16,17 
one case–control study,18 and one paper analyzing longi-
tudinal data reporting information relating to dysmobility 
syndrome.19 There were no identified intervention studies of 
any nature investigating approaches to slow down or reverse 
progression of dysmobility syndrome. Table 2 outlines the 
characteristics and findings of the included studies.
Population and participants
Overall, there were 9,561 participants included in the five 
non-review studies. The largest study was a cross-sectional 
study of 6,070 females from Korea,18 while Looker included 
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2,875 participants in his prospective cohort study based in 
the USA. The participants from the Looker’s study were 
followed-up for 9–12 years and were from the National 
Health and Nutrition Examination Survey (NHANES) – a 
large representative survey of people aged $50 years.19 Other 
studies had ,300 participants and equal numbers of males 
and females, with the exception of the case–control study in 
Italy, which included females only.17 The mean age of the 
samples in the four studies reporting this ranged from 67.2 
to 80.7 years (the other study by Looker included a sample 
aged .50 years, with 34% aged .70 years).19
Dysmobility measures
Most of the studies utilized variations of the measures and 
cut points in their dysmobility syndrome assessments to those 
originally reported by Binkley et al.9 In part, this may be due 
to several of these studies being based on secondary analyses 
of existing data sets, which may have utilized varying 
measures or cut points for a specific assessment item. Three 
of the papers used the same six cut points as Binkley et al,9 
but Looker19 used different cut points for low muscle strength, 
osteoporosis, and falling risk; Ioloascon et al17 used different 
cut points or definitions for low lean mass, slow gait speed, 
low grip strength, and obesity; and Clynes et al16 used a dif-
ferent definition for obesity. One paper18 appeared to utilize 
a moderately different classification system, classifying 
dysmobility syndrome if all three criteria of high fat mass, 
falls in past 2 years, and osteoporosis were present (instead 
of any three of the six measures reported by Binkley et al 
being present).
Findings of the studies
The prevalence of dysmobility syndrome differed according 
to measurements used in defining dysmobility syndrome and 
the population. It was reported to be 34%,9 24.8%,16 and 
22%19 across three of the studies. Lim and Noh18 reported 
0.7% of their sample had dysmobility syndrome, however, 
as noted before, their differing criteria for classification limit 
comparison to the other studies. An increased prevalence 
of dysmobility syndrome has been reported with increas-
ing age, being present in 17.9% of those aged 70–74 years; 
24.5% of those aged 74–78 years; and 32.1% of those aged 
78–82 years.9
In the small number of studies reporting data on dysmo-
bility syndrome, only one has reported prevalence of each 
of the individual factors comprising the overall dysmobility 
syndrome score.19 In this sample for those aged 50–69 years, 
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muscle mass in 14.9%, lumbar spine osteoporosis in 4.7%, 
and high percent body fat in 56.8%. Higher prevalence 
of each of the component factors was evident for those 
aged $70 years in this sample. Several studies also reported 
average scores on some or all of the individual component 
scores for those with and without dysmobility syndrome. The 
only component of dysmobility syndrome reported separately 
for its prevalence in the investigated sample across multiple 
studies was for “recent falls”, which was reported as being 
present in between 20.7% and 25.5% of these samples.9,16,17 
Looker19 reported the distribution of the number of individual 
component conditions making up the dysmobility syndrome 
score, with those aged 50–69 years having a median of one 
component condition, and those aged $70 years having a 
median of two component conditions, and a greater propor-
tion of the sample with three to six component conditions 
meeting the specified dysmobility syndrome criteria. Impor-
tantly, the study by Binkley et al9 compared the ability of two 
measures of sarcopenia and a measure of lean muscle mass 
with the use of the proposed dysmobility syndrome domains 
and criteria and showed that the dysmobility syndrome mea-
sure captured the majority of those identified at risk by the 
other measures, while also identifying a substantial differ-
ent at risk population from the same sample. Similarly, the 
dysmobility syndrome classification appeared to identify a 
greater at risk population than several measures of skeletal 
muscle function deficit, including sarcopenic skeletal muscle 
function deficit.17
Several studies investigated the association between 
the presence of dysmobility syndrome and other indicators 
of adverse health outcomes. The cross-sectional study by 
Lim and Noh identified significantly lower physical function 
for the small subsample with dysmobility syndrome.18 
Several studies reported falls or fracture rates for par-
ticipants meeting the criteria for dysmobility syndrome: 
Iolascon et al17 reported increased risk of fragility fractures 
(odds ratio [OR], 2.46; 95% confidence interval [CI], 
1.04–5.81); Clynes et al16 reported an association with falls 
in the last year (OR, 5.53; CI, 3.03–10.1) and falls since 
age 45 (OR, 2.54; CI, 1.34–4.81), but no association with 
fractures since age 45.
Investigating the outcome of mortality, Looker19 fol-
lowed participants from a baseline assessment of dys-
mobility syndrome in 1999–2001 until December 2011. 
Dysmobility syndrome was associated with significantly 
greater mortality (45% of those with dysmobility syndrome at 
baseline died, compared to 15% of those without dysmobility 
syndrome). A differential magnitude of risk was identified 
with age, with attenuation of the risk in older age groups 
(those aged .70 years).
Discussion
Dysmobility syndrome is a recently described multicompo-
nent classification that aims to improve use in clinical practice 
and research of approaches to identify early those older people 
most at risk of future adverse outcomes and improve early 
implementation of effective interventions.9 This review has 
highlighted the small number of papers reporting any aspect 
of dysmobility syndrome. However, the limited research 
available to date provides preliminary support for this broader 
classification system than others that have been utilized previ-
ously, including those of sarcopenia and frailty.
The concept of dysmobility syndrome has developed from 
a range of other literature that has considered the need to focus 
more broadly on a cluster of factors that may adversely impact 
on health and wellbeing outcomes for older people, rather 
than multiple narrow factors being looked at in isolation. For 
example, some of the sarcopenia literature has highlighted 
the need for this more holistic approach.8,16,17,20 Morley et al 
also described “sarcopenia with limited mobility” further 
recognizing the importance of consideration of additional 
mobility domains to the sarcopenia classification.7
For widespread utilization, classifications such as this 
need to be 1) accurate; 2) be practical and able to be readily 
utilized in clinical settings; and 3) amenable to successful 
intervention. With respect to accuracy, there appears to be a 
need to more clearly define several of the contributory fac-
tors of dysmobility syndrome. The six factors defined in the 
Binkley et al’s study initially reporting dysmobility syndrome 
were described in the context of:
cutpoint values are arbitrary, potentially contentious and 
may very well require refinement and alteration if the dys-
mobility syndrome concept moves forward.9
A number of the papers cited in this review have used 
existing data sets, which appear to have utilized in some 
cases measures of a factor or cut points that differ from those 
described by Binkley et al.9 For example, Looker utilized 
“risk of falling” defined as:
having problems with balance based on a single question-
naire item that asked respondents if they had dizziness, 
difficulties with balance or difficulties with falling in the 
past 12 months19
in contrast to the factor classification by Binkley and col-
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differences are likely to affect the research outcomes being 
reported. There is a need for clear operationalization and 
standardization of the component factors of dysmobility 
syndrome.
The history of falls factor does add an important 
consideration to those associated with muscle and bone. 
However, history of falls can be problematic. Up to 20% of 
older people forget falls, particularly minor falls, when asked 
about falls in the preceding 12 months.21 Furthermore, many 
older people do not report falls to their health practitioners, 
for various reasons.22 In addition, by the time a fall occurs, 
often a moderate level of falls risk has developed. There may 
be greater value in identifying older people with increasing 
falls risk before a fall actually occurs. One or more mea-
sures of balance performance might be useful to consider to 
complement or be included instead of the existing measure 
of 12-month history of falls. However, further research is 
required to determine whether a measure of balance per-
formance might yield better discrimination than the history 
of falls items. If this were to occur, there would be a need 
to determine the most useful single test of standing balance 
performance, of the many tests available.23
There is also considerable discussion about the most 
useful cut point for at least one of the six factors – gait 
speed, with most recommendations for cut points of 
1 m/s or 0.8 m/s.2,7,8 In recent years, an Asian consensus 
report on sarcopenia has recommended the cut point of 
0.8 m/s,6 in contrast to the 1.0 m/s recommended by the 
International working group2 and the European working 
group.24 The Asian modified cut point on this and other 
domains evaluated for the diagnosis of sarcopenia were 
developed based on Asian data, reflecting different perfor-
mance outcomes (in part likely to be related to different 
anthropometric measures).
Of note, there were no intervention studies identified 
in the systematic review. A recent systematic review high-
lighted that a number of exercise interventions were effective 
in improving outcomes for older people with sarcopenia, 
although nutrition interventions were equivocal.4 The exer-
cise interventions for sarcopenia primarily focus on muscle 
strength training. However, there is strong research evidence 
particularly for exercise-related interventions to improve a 
range of other adverse outcomes for at risk older people, 
including falls and fractures,25 balance performance,26 and 
function.27 However, specificity of training and ensuring 
safety, particularly when incorporating balance-related 
exercises, mean that care needs to be applied in prescribing 
appropriate exercises for the desired outcomes. Most likely 
of benefit across a range of domains would be multimodal 
exercises that include some balance, strength training, and 
cardiovascular fitness exercises. These type of exercise pro-
grams have been shown to be safe and feasible and effective 
in improving physical performance in older people with mild 
levels of functional impairment,28 through to samples with 
more advanced health problems29 and those with cognitive 
impairment.30,31
A limitation of the emerging research in the area of dys-
mobility syndrome is that although there has been general 
consistency in the six factors included in the classification, 
there have been somewhat varied approaches to ascertaining 
the presence or absence of the factor, which is likely to impact 
on the classification accuracy and ability to make direct 
comparisons between studies. The research to date provides 
preliminary support for the wider application of dysmobility 
syndrome in research, and for consideration for clinical prac-
tice, however, there will need to be more stringent operational 
definitions utilized for each of the factors.
In summary, the small amount of research investigating 
dysmobility syndrome since it was originally described by 
Binkley et al9 in 2013 suggests that it may be a useful clas-
sification system warranting further investigation. There may 
be value in considering the use of a single standing balance 
test item in place of, or as well as the falls history indicator, 
given some limitations noted with this factor. There is a need 
for further research to achieve standardization of definitions 
and cut points to determine the value of the dysmobility 
classification system in accurate and early classification of 
risk of future adverse health outcomes and effectiveness of 
interventions to improve longer-term outcomes for those 
classified with dysmobility syndrome.
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